RNU6-1213P

Across TCGA pan-cancer cohorts, RNU6-1213P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RNU6-1213P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RNU6-1213P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1213P expression acts as an unfavorable survival marker.

BRCA, KIRC, and PAAD are the cancer types where RNU6-1213P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	All	0.697	0.905	<.001	120	view →
KIRC	DFS	Tertile	III,IV	0.437	0.757	.001	99	view →
PAAD	DFS	Tertile	All	0.100	0.505	.004	72	view →
LUAD	OS	Tertile	All	0.161	0.788	.001	54	view →
CHOL	DFS	Tertile	All	0.045	0.486	.009	45	view →
DLBC	DFS	Tertile	All	0.099	0.771	.002	36	view →
SARC	OS	Tertile	All	0.022	0.861	<.001	27	view →
TGCT	DFS	Tertile	All	0.067	0.802	.001	18	view →
LIHC	DFS	Tertile	All	0.146	0.529	.027	18	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
KIRP	OS	Tertile	All	0.279	0.713	.008	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RNU6-1213P–BRCA (DFS)

Open the BRCA breakdown →